Kinnate Biopharma Inc.
INHIBITORS OF RAF KINASES
Last updated:
Abstract:
Provided herein are heteroaryl inhibitors of receptor tyrosine kinase effector (RAF), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of disease.
Status:
Application
Type:
Utility
Filling date:
30 Apr 2020
Issue date:
5 Nov 2020